These compounds may interact with:
M-phase inducer phosphatase 2
Potentially involved in: carcinoma; bipolar disorder; cancer; amyotrophic lateral sclerosis type 2; chemical and drug induced liver injury; active crohn's disease; adrenocortical carcinoma; atopic dermatitis; breast cancer; esophageal adenocarcinoma; gastric carcinoma; interstitial cystitis; intraductal papillary-mucinous carcinoma (ipmc); intraductal papillary-mucinous neoplasm (ipmn); malignant mesothelioma; osteosarcoma; psoriasis; ulcerative colitis
Disease data sourced from Pharos.